Good news! ish. Although we didn’t see any reporting on any attempt to trigger the rescission via notification of Congress on 8/15, there was always the concern that NIH would follow regime preferences. So I was eager to see if any awards would be issued from 8/16 onward. Of course, given the update cycle of … … Continue reading →| DrugMonkey
Propublica has published a report on the loss of staff positions at various government agencies since January of 2025. This includes a list of percent losses at each NIH IC due to firings, layoffs,…| DrugMonkey
Researchers like Richard Huganir are closing in on a cure for SYNGAP1-related disorders. But in the face of federal funding cuts, can they finish what they started?| The Hub
NIH released several important notices over the last few weeks. Below is a brief summary of each item. To read each complete notice (NOT): https://grants.nih.gov/policy-and-compliance/notice-of-policy-changes Supporting Fairness and Originality in NIH Research Applications. NIH is evaluating applications closely for substantial use of AI. NIH also will now only accept a maximum of 6 applications per […]| Bouvier Grant Group
Following up on yesterday’s whinesplaining about the relative difficulty of getting a NIH grant across pertinent career eras, I had some more thoughts on generational expectations and gasligh…| DrugMonkey
There’s a parable about a coyote and a rabbit that ends with the coyote being criticized by a bystander after observing his fruitless chase. The coyote observed, “I was only running for…| DrugMonkey
You have an idea for a full-scale clinical trial that you would like to eventually fund with an R01. How do you go from concept to R01 funding for the full-scale trial? NIH has several funding mechanisms that can help you lay the groundwork for a future R01-funded trial. Here, we outline some of the […] The post Spotlight on R34, R21, R61/R33: NIH Mechanisms to Help You Prepare for a Future R01-funded clinical trial appeared first on Bouvier Grant Group.| Bouvier Grant Group
The NIH DP2 activity code supports highly innovative research by new investigators in all areas of biomedical and behavioral research. NIH currently has three active DP2 Notices of Funding Opportunity (NOFO). We’ve summarized them for you below. It is always a good idea to speak with the program officers of these NOFOs to determine whether […] The post A Comparison of 3 NIH New Innovator Awards (DP2): Office of the Director High-Risk, High-Reward; NIDA; and NIAID appeared first on Bouvier...| Bouvier Grant Group
I have received a lot of requests lately for help writing an NIH rebuttal, so it seems like a good time to talk about what they are and how to write one. Rebuttals seem to go in and out of vogue at NIH, and for whatever reason right now, many program officers (POs) are requesting […]| Bouvier Grant Group
Among the 187 US institutions described as a R1 for 2025, Howard University has been included for the first time. This is the first Historically Black College or University (HBCU) to achieve this high level of research activity and this is a very welcome bit of news. For those not familiar, the Carnegie rankings are […]| Drugmonkey
[Update: The Chronicle is reporting as of 2/10/2025 that F31-diversity applications have been re-instated to the study sections for review. If true, this is excellent news.] One of the primary NIH training fellowships is the Ruth L. Kirschstein Predoctoral Individual National Research Service Award for graduate students, aka, the F31. It is requested with individual […]| Drugmonkey
Detection of cancer before a clinical diagnosis could give patients and caregivers more time for intervention and may lead to better outcomes because tumors are more likely to be curable| The Hub
A genetic mutation and evolutionary trick fuels horses' exceptional athleticism, findings that may advance scientific understanding and treatments for inherited and age-related diseases in people| The Hub
Falls are the leading cause of injury-related death among seniors in the United States. Johns Hopkins researcher Kathleen Cullen studies the vestibular system in our inner ear, integral to maintaining balance.| The Hub
JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars Program, an initiative that has led to research and treatment breakthroughs for the genetic condition neurofibromatosis type 1| The Hub
NIH has issued NOT-OD-25-132 Supporting Fairness and Originality in NIH Research Applications which informs us that NIH will only accept six new, renewal, resubmission, or revision applications fro…| DrugMonkey
I ran across a clip of the current Director of the NIH and the prior Acting Director (and current Principal Deputy Director of the NIH) expressing great concern about scientists in training. As per…| DrugMonkey
The NIH Director’s New Innovator Award (activity code DP2) supports Early-Stage Investigators (ESIs) who are pursuing highly innovative research that has the potential to have a major impact on areas relevant to NIH mission. Applications can be basic, translational, or clinical in nature. The Notice of Funding Opportunity (RFA-RM-25-002) allows for clinical trials, though it […] The post Spotlight on the NIH Director’s New Innovator Award – DP2 appeared first on Bouvier Grant Group.| Bouvier Grant Group
Health science researchers in the U.S. naturally gravitate toward National Institutes of Health (NIH) grants to fund their work, but other sources are available. And with the looming threat of NIH budget cuts, interest in alternatives may be on the rise. One such (perhaps surprising?) resource: the U.S. Department of Defense (DOD). You’re familiar with […]| Bouvier Grant Group
Health science researchers in the U.S. naturally gravitate toward National Institutes of Health (NIH) grants to fund their work, but other sources are available. And with the looming threat of NIH budget cuts, interest in alternatives may be on the rise. One such (perhaps surprising?) resource: the U.S. Department of Defense (DOD). You’re familiar with […]| Bouvier Grant Group
I receive a lot of questions from worried applicants and clients about how to navigate the volatile NIH funding landscape.| Bouvier Grant Group
The Center on Aging and Health, one of JHU's largest recipients of NIH funds, conducts critical work that provides real-time insights into the condition and care of older Americans| The Hub
Dr. Francis Collins recently announced his retirement from the federal government after a long and distinguished career in service. Many people have already written about his illustrious career. I had the great fortune to work for Dr. Collins, so I thought I would share some of my memories of him. While I was working as […] The post Dr. Bouvier’s Personal Memories of Dr. Francis Collins, retired NIH Director. appeared first on Bouvier Grant Group.| Bouvier Grant Group
For over 40 years, the U.S. federal government has provided non-dilutive funding for small businesses across the country through the Small Business Innovation Research (SBIR) programs. Ten years after the initiation of SBIR, a companion effort was launched to support small businesses partnerships with research institutions, the Small Business Technology Transfer (STTR) programs. SBIR and/or […] The post SBIR/STTR still going strong, but will it be renewed? appeared first on Bouvier Gran...| Bouvier Grant Group
Backed by NIH funding, Muyinatu 'Bisi' Bell's innovative work is enhancing diagnostic accuracy, improving surgical precision, and ensuring equitable health care for all patients| The Hub
Electrical engineer Mounya Elhilali relies on federal funding to push the boundaries of how technology can enhance human perception| The Hub
As research funding becomes increasingly competitive, organizations seek resources to give their researchers an advantage.| Bouvier Grant Group
Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels of specific cellular proteins| The Hub
In February 2024, we brought you a first installment regarding AI and grantwriting courtesy of colleague and guest writer Dr. Agnella Izzo Matic. As you may imagine, the topic of AI as a whole and, similarly, AI as it relates to grantwriting and scientific writing is evolving. For a bit of background into what AI is, […]| Bouvier Grant Group
Guest Post by Dr. Agnella Izzo Matic TL;DR – AI is a new tool that can (and should) be leveraged to speed up some specific parts of the writing process that can be automated – saving time and mental bandwidth for the parts of the process that need idea generation and critical analysis. AI won’t […]| Bouvier Grant Group